BMC Medical Co. Ltd. A - Asset Resilience Ratio

Latest as of March 2026: 47.31%

BMC Medical Co. Ltd. A (301367) has an Asset Resilience Ratio of 47.31% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥1.60 Billion

≈ $233.75 Million USD Cash + Short-term Investments

Total Assets

CN¥3.38 Billion

≈ $494.09 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2020–2025)

This chart shows how BMC Medical Co. Ltd. A's Asset Resilience Ratio has changed over time. See financial agility of BMC Medical Co. Ltd. A to measure the company's free cash flow as a share of total liabilities.

Liquid Assets Composition Over Time

This chart breaks down BMC Medical Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see BMC Medical Co. Ltd. A (301367) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.60 Billion	47.31%
Total Liquid Assets	CN¥1.60 Billion	47.31%

Asset Resilience Insights

Very High Liquidity: BMC Medical Co. Ltd. A maintains exceptional liquid asset reserves at 47.31% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

BMC Medical Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare BMC Medical Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hangzhou Alltest Biotech Co. Ltd. A SHG:688606	Medical Instruments & Supplies	11.88%
Daxor Corporation NASDAQ:DXR	Medical Instruments & Supplies	65.10%
Ansell Ltd AU:ANN	Medical Instruments & Supplies	7.53%
Nanosonics Ltd AU:NAN	Medical Instruments & Supplies	46.84%
SDI Ltd AU:SDI	Medical Instruments & Supplies	3.36%
Austco Healthcare Ltd AU:AHC	Medical Instruments & Supplies	15.90%
Trajan Group Holdings Ltd AU:TRJ	Medical Instruments & Supplies	0.29%
Osteopore Ltd AU:OSX	Medical Instruments & Supplies	22.60%

Annual Asset Resilience Ratio for BMC Medical Co. Ltd. A (2020–2025)

The table below shows the annual Asset Resilience Ratio data for BMC Medical Co. Ltd. A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	44.76%	CN¥1.52 Billion ≈ $221.73 Million	CN¥3.38 Billion ≈ $495.33 Million	-21.97pp
2024-12-31	66.74%	CN¥2.29 Billion ≈ $334.47 Million	CN¥3.42 Billion ≈ $501.16 Million	+4.64pp
2023-12-31	62.10%	CN¥1.81 Billion ≈ $265.22 Million	CN¥2.92 Billion ≈ $427.07 Million	-11.70pp
2022-12-31	73.80%	CN¥2.16 Billion ≈ $316.08 Million	CN¥2.93 Billion ≈ $428.28 Million	+26.50pp
2021-12-31	47.30%	CN¥295.00 Million ≈ $43.17 Million	CN¥623.69 Million ≈ $91.27 Million	+20.78pp
2020-12-31	26.52%	CN¥124.00 Million ≈ $18.15 Million	CN¥467.64 Million ≈ $68.43 Million	--

pp = percentage points

About BMC Medical Co. Ltd. A

SHE:301367 China Medical Instruments & Supplies

Market Cap

$817.65 Million

CN¥5.59 Billion CNY

Market Cap Rank

#9699 Global

#2455 in China

Share Price

CN¥44.60

Change (1 day)

+0.54%

52-Week Range

CN¥38.58 - CN¥99.35

All Time High

CN¥225.96